Hannah Brendan 4
4 · Quince Therapeutics, Inc. · Filed Jun 5, 2024
Insider Transaction Report
Form 4
Hannah Brendan
CBO, COO & CCO
Transactions
- Exercise/Conversion
Common Stock
2024-06-04$0.55/sh+56,061$30,834→ 257,616 total - Exercise/Conversion
Employee Stock Option (right to buy)
2024-06-04−56,061→ 47,439 totalExercise: $0.55Exp: 2032-03-27→ Common Stock (56,061 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments over the following three years.